Cancer risk and mortality in users of calcium channel blockers

This publication has 24 references indexed in Scilit:

• Verapamil and risk of cancer in patients with coronary artery disease
  The American Journal of Cardiology, 1999
• Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem
  Cancer, 1999
• Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. Women
  Cancer, 1998
• Calcium Antagonists and Cancer
  Drug Safety, 1998
• Cancer Risk in Users of Calcium Channel Blockers
  Hypertension, 1997
• Calcium-channel blockers and risk of cancer
  The Lancet, 1997
• Final Outcome Results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
  JAMA, 1996
• Calcium-channel blockade and incidence of cancer in aged populations
  The Lancet, 1996
• Calcium antagonists and mortality in patients with coronary artery disease: A Cohort study of 11,575 patients
  Journal of the American College of Cardiology, 1996
• Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells
  British Journal of Cancer, 1995